This metered-dose nasal spray has strong anti-allergic and anti-inflammatory properties. The drug "Tafen-nasal", the instruction to which indicates the need to use only therapeutic doses, does not have a resorptive effect.
The active substance of this drug is budesonide. 1 dose of the drug contains 50 mcg of this substance. In a dark blue glass canister there is a white homogeneous suspension consisting of budesonide and excipients (methyl parahydroxybenzoate, microcrystalline cellulose, propyl parahydroxybenzoate, sodium carboxymethyl cellulose, simethicone emulsion, polysorbate 80, propylene glycol hydrochloride , hydrochloric acid , sugar, hydrochloride ). Each can is designed for 200 doses. It is equipped with a metering mechanical device with a special nozzle tip, which is very convenient to use.
In what cases is the preparation "Tafen" indicated? Instructions for him recommend using this spray for allergic rhinitis, inflammation of the upper respiratory system. This medicine is well tolerated and does not have corticoid activity. The drug increases the synthesis of anti-inflammatory proteins, reduces the number of mast cells and eosinophilic granulocytes. Thanks to budesonide, the release of toxic proteins, free radicals from macrophage cells, as well as lymphokines from lymphocytes, is reduced. In the process of drug exposure, the adhesion of molecules to endothelial cells decreases, so the influx of leukocytes into inflamed areas is greatly reduced. The drug affects the inhibition of the synthesis of leukotrienes, prostaglandins and PAFs, which induce an inflammatory reaction.
The drug "Tafen-nasal", the instruction to which guarantees a reduction in the severity of symptoms of allergic rhinitis, effectively suppresses the early and late phases of an allergic reaction. It relieves severe airway inflammation. A noticeable improvement is observed for 2-3 days.
The drug "Tafen-nasal": instructions for use
Children after 6 years and adults: at the beginning of treatment - 2 doses of 2 r. per day (in each nostril). Maintenance doses that relieve the symptoms of rhinitis - 1 dose 2 r. per day or 2 doses of 1 r. per day (in each nostril). A single maximum dose is 100 mcg in each nostril, a daily maximum dose is 400 mcg (3-month course of administration).
The full therapeutic effect of taking the drug is observed with proper and regular use. If the dose is missed, it should be taken as soon as possible. Between receptions, the interval should be at least 1 hour.
Side effects: irritation of the mucous membrane of the throat and nose, nosebleeds, cough, dry mouth, sneezing, rash, urticaria, dermatitis, dizziness, fatigue. Cases of angioedema, growth retardation, perforation of the nasal septum, tachycardia, loss of smell are very rarely observed.
Contraindications to the use of the drug "Tafen-nasal", the instruction for which does not allow its use for children under 6 years old, are infectious diseases of the respiratory system caused by fungi, bacteria, various viruses; pulmonary tuberculosis; hypersensitivity to the components of this drug.
The drug "Tafen-nasal" during pregnancy is prescribed only when the benefits of the medicine for the mother exceed the expected harm to the unborn child. Breastfeeding stops when using the medication during lactation.
With prolonged use of large doses, symptoms of hypercorticism may occur. When they appear, the drug is stopped taking, gradually reducing the dose. This medicine from pharmacies is available on prescription. The drug is stored for 2 years at room temperature.